Design Therapeutics, Inc. (DSGN)

NASDAQ: DSGN · IEX Real-Time Price · USD
0.34 (3.07%)
May 20, 2022 4:00 PM EDT - Market closed

Total Valuation

DSGN has a market cap or net worth of $635.92 million. The enterprise value is $267.71 million.

Market Cap635.92M
Enterprise Value267.71M

Important Dates

The latest earnings date was Monday, May 9, 2022, before market open.

Last Earnings DateMay 9, 2022
Ex-Dividend Daten/a

Share Statistics

DSGN has 55.78 million shares outstanding. The number of shares has increased by 214.84% in one year.

Shares Outstanding55.78M
Shares Change (YoY)+214.84%
Shares Change (QoQ)+20.84%
Owned by Insiders (%)36.84%
Owned by Institutions (%)68.31%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio1.72
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 68.23, with a Debt / Equity ratio of 0.01.

Current Ratio68.23
Quick Ratio67.74
Debt / Equity0.01
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -11.20%, which is considered low. The company has a ROIC of -69.20%.

Return on Equity (ROE)-11.20%
Return on Assets (ROA)-11.00%
Return on Capital (ROIC)-69.20%
Revenue Per Employeen/a
Profits Per Employee-$983,727
Employee Count44
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-58.45%
50-Day Moving Average13.18
200-Day Moving Average15.73
Average Volume (30 Days)157,535

Short Selling Information

The latest short interest is 4.06 million, so 7.29% of the outstanding shares have been sold short.

Short Interest4.06M
Short % of Shares Out7.29%
Short % of Float23.00%
Short Ratio (days to cover)28.83

Income Statement

Gross Profitn/a
Operating Income-43.52M
Net Income-43.28M
Earnings Per Share (EPS)-$0.78
Full Income Statement

Balance Sheet

The company has $371.22 million in cash and $3.01 million in debt, giving a net cash position of $368.21 million or $6.60 per share.

Cash & Cash Equivalents371.22M
Total Debt3.01M
Net Cash368.21M
Net Cash Per Share$6.60
Book Value370.31M
Book Value Per Share6.64
Working Capital368.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$37.51 million and capital expenditures -$1.58 million, giving a free cash flow of -$39.09 million.

Operating Cash Flow-37.51M
Capital Expenditures-1.58M
Free Cash Flow-39.09M
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-6.81%
FCF Yield-6.15%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-214.84%
Shareholder Yield-214.84%
Dividend Details

Analyst Forecast

The average price target for DSGN is $28.05, which is 146.05% higher than the current price. The consensus rating is "Buy".

Price Target$28.05
Price Target Difference146.05%
Analyst ConsensusBuy
Analyst Count9
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a